[HTML][HTML] Diversity in the emergency care for febrile children in Europe: a questionnaire study
D Borensztajn, S Yeung, NN Hagedoorn… - BMJ paediatrics …, 2019 - ncbi.nlm.nih.gov
Original article: Diversity in the emergency care for febrile children in Europe: a questionnaire
study - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …
study - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …
Once-per-cycle pegfilgrastim versus daily filgrastim in pediatric patients with Ewing sarcoma
G Wendelin, H Lackner, W Schwinger… - Journal of Pediatric …, 2005 - journals.lww.com
The use of the recombinant human granulocyte colony-stimulating factor filgrastim to shorten
the duration of severe neutropenia after cytotoxic chemotherapy has become an integral part …
the duration of severe neutropenia after cytotoxic chemotherapy has become an integral part …
Catheter closure of the persistent foramen ovale: Mid‐term results in 162 patients
A BEITZKE, H SCHUCHLENZ… - Journal of …, 2001 - Wiley Online Library
Four different types of occluder systems were used to close a persistent foramen ovale
(PFO) in 162 patients with paradoxical embolic events. Ninety‐eight patients had ischemic …
(PFO) in 162 patients with paradoxical embolic events. Ninety‐eight patients had ischemic …
PHACES: a neurocutaneous syndrome with anomalies of the aorta and supraaortic vessels
G Wendelin, E Kitzmüller, U Salzer-Muhar - Cardiology in the Young, 2004 - cambridge.org
The acronym PHACES summarizes the most important manifestations of a rare
neurocutaneous syndrome. Specifically,“P” accounts for malformation of the brain in the …
neurocutaneous syndrome. Specifically,“P” accounts for malformation of the brain in the …
Peripheral blood stem cell mobilization with pegfilgrastim compared to filgrastim in children and young adults with malignancies
P Fritsch, W Schwinger, G Schwantzer… - Pediatric Blood & …, 2010 - Wiley Online Library
Background Pegfilgrastim, the long acting agent of rh‐GCSF, has been shown to be as
effective as Filgrastim in children undergoing cytotoxic chemotherapy by reducing the …
effective as Filgrastim in children undergoing cytotoxic chemotherapy by reducing the …
Differentiating inherited human herpesvirus type 6 genome from primary human herpesvirus type 6 infection by means of dried blood spot from the newborn screening …
V Strenger, K Pfurtscheller, G Wendelin… - The Journal of …, 2011 - Elsevier
To differentiate active human herpesvirus type 6 (HHV-6) infection from inherited HHV-6
(iHHV-6), we analyzed dried blood spots from archived newborn screening cards in 3 …
(iHHV-6), we analyzed dried blood spots from archived newborn screening cards in 3 …
Chromosomal integration of the HHV-6 genome as a possible cause of HHV-6 detection in cardiac tissues
V Strenger, SW Aberle, G Wendelin… - Journal of clinical …, 2010 - jcp.bmj.com
After reading a recent article by Moon et al, 1 we offer our experience and opinion in relation
to autoimmunity because we observed a rather different result in our hepatitis A virus (HAV) …
to autoimmunity because we observed a rather different result in our hepatitis A virus (HAV) …
Once Per Cycle Pegfilgrastim Versus Daily Filgrastim in Pediatric Patients with Ewing Sarcoma.
G Wendelin, H Lackner, W Schwinger, P Sovinz… - 2004 - ashpublications.org
The administration of the recombinant human granulocyte colony-stimulating factor (rhG-
CSF) Filgrastim for reducing the duration of severe neutropenia after cytotoxic chemotherapy …
CSF) Filgrastim for reducing the duration of severe neutropenia after cytotoxic chemotherapy …
The implementation of" Intranet based therapeutic schemata" for comprehensive diagnostic and therapy guidelines
AE Sonnleitner, G Wendelin, J Jahnel, S Bauchinger… - Safety in Health, 2015 - Springer
The implementation of "Intranet based therapeutic schemata" for comprehensive diagnostic
and therapy guidelines | Safety in Health Skip to main content SpringerLink Account Menu …
and therapy guidelines | Safety in Health Skip to main content SpringerLink Account Menu …
Risk of Confusion in the Prescription and Administration of Generic Drugs
G Wendelin, S Löffler, E Thierrichter, A Sonnleitner… - Safety in Health, 2015 - Springer
Background In Austria physicians are legally obligated to use trade names instead of active
components when prescribing drugs. The increasing number of generics and short term …
components when prescribing drugs. The increasing number of generics and short term …